US Stock MarketDetailed Quotes

VSTM Verastem

Watchlist
  • 10.3600
  • +0.3800+3.81%
Close May 2 16:00 ET
  • 10.3600
  • 0.00000.00%
Post 16:00 ET
262.19MMarket Cap-2616P/E (TTM)

About Verastem Company

Verastem, Inc. is a biopharmaceutical company, which engages in the development and commercialization of drugs for the treatment of cancer. The company was founded by Richard H. Aldrich, Michelle Dipp, Piyush Gupta, Satish Jindal, Eric S. Lander, Robert F. Weinberg, and Christoph H. Westphal on August 4, 2010 and is headquartered in Needham, MA.

Company Profile

SymbolVSTM
Company NameVerastem
Listing DateJan 27, 2012
Issue Price10.00
Founded2010
CEOMr. Daniel Paterson
MarketNASDAQ
Employees73
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address117 Kendrick Street,Suite 500
CityNeedham
ProvinceMassachusetts
CountryUnited States of America
Zip Code02494
Phone1-781-292-4200
Websitehttp://www.verastem.com

Company Executives

  • Name
  • Position
  • Salary
  • Daniel Paterson
  • Director, President and Chief Executive Officer
  • 3.63M
  • Daniel Calkins
  • Chief Financial Officer and Chief Accounting Officer
  • 622.56K
  • Brian M. Stuglik, R.Ph.
  • Director
  • 2.02M
  • Robert Gagnon, M.B.A.
  • Director
  • 64.29K
  • Dr. Paul Bunn, M.D.
  • Independent Director
  • 74.29K
  • John H. Johnson
  • Independent Director
  • 81.29K
  • Dr. Michael Glen Kauffman, M.D.,PhD
  • Lead Independent Director
  • 124.29K
  • Anil Kapur
  • Independent Director
  • 81.75K
  • Dr. Eric K. Rowinsky,M.D.
  • Independent Director
  • 89.29K
  • Dr. Karin Tollefson
  • Independent Director
  • 93.49K
  • Michelle Robertson
  • Independent Director
  • 84.29K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg